<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04174183</url>
  </required_header>
  <id_info>
    <org_study_id>2019-A02416-51</org_study_id>
    <nct_id>NCT04174183</nct_id>
  </id_info>
  <brief_title>Evaluation of the Effectiveness of a Closed-incision Negative-pressure Therapy (Prevena®) on Bilateral Groin Incision</brief_title>
  <acronym>PREVISION</acronym>
  <official_title>Evaluation of the Effectiveness of a Closed-incision Negative-pressure Therapy (Prevena®) on Bilateral Groin Incision</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Closed-incision negative-pressure therapy are medical device that are suspected to reduce&#xD;
      groin wound complication in vascular surgery. The aim of this study is to compareon on the&#xD;
      same patient a Closed-incision negative-pressure therapy (Prevena®, KCI) versus a traditional&#xD;
      gauze dressings after a bilateral vascular groin surgery. To do this, each device is applied&#xD;
      on one groin incision and the side, left or right, is randomized.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The prevalence of surgical site infections in groin vascular surgery is 3-44%. The factors&#xD;
      causing these infections are well identified: disruption of lymphatic vessels, proximity of&#xD;
      genital organs, presence of prosthetic material, etc. The risk of developing an infection of&#xD;
      the surgical site is also influenced by the patient's comorbidities and by the surgical&#xD;
      context.&#xD;
&#xD;
      Closed-incision negative-pressure therapy are medical device that are suspected to reduce&#xD;
      groin wound complication in vascular surgery. The mechanisms of action for negative-pressure&#xD;
      therapy include protecting the wound bed, splinting soft tissue, reducing oedema,increasing&#xD;
      perfusion and enhancing development of granulation tissue.&#xD;
&#xD;
      Presently, there are no guidelines for the use of this device or not in groin incision and&#xD;
      this decision is left to the surgeon's discretion.&#xD;
&#xD;
      The main objective is to demonstrate the superiority of closed-incision negative-pressure&#xD;
      therapy over the application of a traditional gauze dressings to reduce the rate of major&#xD;
      complications (i.e. requiring an extension of hospitalization time) during bilateral vascular&#xD;
      groin surgery. To do this, each device is applied on one groin incision and the side, left or&#xD;
      right, is randomized.&#xD;
&#xD;
      The secondary objectives are:&#xD;
&#xD;
        1. To demonstrate the superiority of closed-incision negative-pressure therapy over the&#xD;
           application of a dry dressing in reducing the score of complications (major and minor)&#xD;
           during vascular groin surgery. The complication score is the number of complications&#xD;
           observed during the consultation conducted on day four after the surgery, among the&#xD;
           following:&#xD;
&#xD;
             -  Major :&#xD;
&#xD;
                  1. Presence of pus&#xD;
&#xD;
                  2. Bloody and/or lymphatic discharge&#xD;
&#xD;
                  3. Disunity&#xD;
&#xD;
                  4. Necrosis&#xD;
&#xD;
             -  Minor :&#xD;
&#xD;
                5) Bruising 6) Hematoma 7) Wound extension&#xD;
&#xD;
        2. To compare the rate of major complications between closed-incision negative-pressure&#xD;
           therapy and dry dressing application in different clinical settings.&#xD;
&#xD;
      3. To demonstrate the superiority of closed-incision negative-pressure therapy over the&#xD;
      application of a dry dressing in reducing the score of complications 2-3 months after&#xD;
      surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 24, 2019</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Wound aspect - major complication</measure>
    <time_frame>4 days</time_frame>
    <description>Left and right wound incision are inspected and the presence of major complication are reported.&#xD;
Major complication :&#xD;
Presence of pus Bloody and/or lymphatic discharge Disunity Necrosis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Score of complications</measure>
    <time_frame>4-days</time_frame>
    <description>Left and right wound incision are inspected and the presence of major and minor complication are reported. A score of complications is established.&#xD;
- Major : Presence of pus Bloody and/or lymphatic discharge Disunity Necrosis&#xD;
- Minor : Bruising Hematoma Wound extension&#xD;
Each complication amount to 1 point on the complication score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major complication in different clinical settings</measure>
    <time_frame>4-days</time_frame>
    <description>Left and right wound incision are inspected and the presence of major complication are reported.&#xD;
Major complication :&#xD;
Presence of pus Bloody and/or lymphatic discharge Disunity Necrosis&#xD;
During the analysis, patient are divided into several group depending of the presence or absence of comorbidities.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wound aspect - major complication (long term)</measure>
    <time_frame>2-3 months</time_frame>
    <description>Left and right wound incision are inspected and the presence of major complication are reported.&#xD;
Major complication :&#xD;
Presence of pus Bloody and/or lymphatic discharge Disunity Necrosis</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Bilateral Vascular Groin Surgery</condition>
  <arm_group>
    <arm_group_label>Prevena (right side) - Dry dressing (left side)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Prevena (left side) - Dry dressing (right side)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Closed-incision Negative-pressure Therapy - Dry dressing</intervention_name>
    <description>A Closed-incision Negative-pressure Therapy is applied on one groin incision - A dry dressing is applied on one groin incision .</description>
    <arm_group_label>Prevena (left side) - Dry dressing (right side)</arm_group_label>
    <arm_group_label>Prevena (right side) - Dry dressing (left side)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Person affiliated to a health insurance system&#xD;
&#xD;
          -  Person who has received full information on the organization of the research and has&#xD;
             signed his or her informed consent&#xD;
&#xD;
          -  Person presenting a bilateral vascular groin surgery&#xD;
&#xD;
          -  Major person&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Person with a known allergy to one of the components of the evaluated product&#xD;
             (including: acrylic or silver-based adhesives)&#xD;
&#xD;
          -  Person with a contraindication to the product(s) being evaluated&#xD;
&#xD;
          -  Non-collaborative or agitated patient&#xD;
&#xD;
          -  Patients with hemostasis problems&#xD;
&#xD;
          -  Persons referred to in Articles L. 1121-5, L. 1121-7 and L1121-8 of the Public Health&#xD;
             Code:&#xD;
&#xD;
          -  Pregnant woman, parturient or breastfeeding mother&#xD;
&#xD;
          -  Minor person (not emancipated)&#xD;
&#xD;
          -  Adult person subject to a legal protection measure (guardianship, curatorship,&#xD;
             protection of justice)&#xD;
&#xD;
          -  Adult person unable to consent&#xD;
&#xD;
          -  Persons deprived of their liberty by a judicial or administrative decision, persons&#xD;
             undergoing psychiatric care pursuant to Articles L. 3212-1 and L. 3213-1.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicla Settembre</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service de chirurgie vasculaire - Centre Hospitalier Régional Universitaire de Nancy - Allée du Morvan - 54511 Vandœuvre-lès-Nancy Cedex</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nicla Settembre, M.D</last_name>
    <phone>+33 3 831 543 84</phone>
    <email>n.settembre@chru-nancy.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier Régional Universitaire de Nancy</name>
      <address>
        <city>Vandoeuvre-lès-Nancy</city>
        <state>Grand Est</state>
        <zip>54500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicla Settembre, M.D.</last_name>
      <phone>+33 3 831 543 84</phone>
      <email>n.settembre@chru-nancy.fr</email>
    </contact>
    <investigator>
      <last_name>Nicla Settembre, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>November 14, 2019</study_first_submitted>
  <study_first_submitted_qc>November 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 22, 2019</study_first_posted>
  <last_update_submitted>May 6, 2020</last_update_submitted>
  <last_update_submitted_qc>May 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Surgical Wound</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

